Porton USA Acquires J-STAR Research for $26M

Expands its research and development capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, said that its wholly-owned subsidiary Porton USA will acquire J-STAR Research, a contract chemistry organization based in South Plainfield, NJ, for $26 million. J-STAR has been serving as an outsourcing partner for the pharmaceutical and biotechnology industries since its inception in 1996. There are currently 47 employees. J-STAR offers services to suppo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters